Patent · US Active

Wafer and capsule formulations with enhanced dissolution rates for fenofibrate

US11497811B2 · kind B2 · utility

0Cited by

4References

15Claims

0Family size

Assignee

LTS Lohmann Therapie-Systeme AG · DE

Inventors

Michael Li · Hillsborough Township, US
Markus Krumme · Neuwied, DE

Key dates

Filing date	Nov 21, 2017
Grant date	Nov 15, 2022
Priority date	—
Expiry date	Nov 21, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P3/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to developing a novel water and capsule formulation using fenofibrate which is difficult to dissolve and control its release rate in vitro. For example, the invention relates to the creation of capsules and wafers comprising: fenofibrate, a surfactant, a carrier wax, a film former, a plasticizer, and optionally a super disintegrant or other ingredients. The invention further relates to the process of forming such capsules and wafers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.